NEW YORK (GenomeWeb) – Danaher today reported a 10 percent year-over-year increase in its third quarter revenues, boosted by a 20 percent increase in sales in its diagnostics segment.

For the three months ending Sept. 29, total sales rose to $4.53 billion, compared to $4.13 in the year-ago period, and beating the consensus Wall Street estimate of $4.47 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.